Assessing antibacterial use practices among in-patients in hospitals in Uganda
This cross-sectional study of nearly 10,000 inpatient antibacterial prescriptions across 79 Ugandan hospitals reveals widespread suboptimal prescribing practices, including limited microbiological testing, heavy reliance on broad-spectrum "Watch" antibiotics, and only 41.3% adherence to national guidelines, highlighting the urgent need for strengthened antimicrobial stewardship interventions.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Hospitals are places where the body's defenses are often at their weakest, making them the frontline battleground against bacterial infections. To fight these invaders, doctors rely on antibacterial medicines, powerful tools that kill bacteria or stop them from multiplying. However, these medicines are not infinite resources. When they are used too often, or used for the wrong reasons, the bacteria they are meant to kill learn how to survive them. This process, known as antimicrobial resistance, turns once-effective medicines into useless ones, leaving patients with infections that are increasingly difficult to treat. To prevent this, health experts have developed rules called treatment guidelines. These are like roadmaps that tell doctors which medicine to choose for a specific illness, how much to give, and for how long. Following these rules is the key to keeping the medicines working for everyone, but in many parts of the world, it is unclear how often doctors actually follow them.
In Uganda, a team of researchers set out to map exactly how antibacterial medicines are being used in hospitals. They looked at nearly ten thousand prescriptions written for patients who were staying in the hospital. This massive review covered 79 different hospitals, ranging from small general facilities to large national referral centers. The goal was to see if doctors were sticking to the national guidelines, what kinds of infections were being treated, and whether there were any patterns in how the medicines were chosen. The researchers examined the records of patients who had received systemic antibacterials, which are drugs that travel through the whole body, rather than just being applied to the skin. They checked if the doctors had written down why they were giving the medicine, if they had taken samples to test for specific bacteria, and whether the drug chosen matched the official recommendations for that specific condition.
The picture that emerged from the data was one of significant opportunity for improvement. The study found that less than half of the prescriptions, specifically 41.3 percent, actually followed the national treatment guidelines. This means that in more than five out of ten cases, the medicine chosen did not match the official recommendation for the patient's condition. A major reason for this disconnect was that in one out of every five prescriptions, the doctor did not write down the reason for giving the medicine at all. Without a clear diagnosis or indication written in the chart, it is impossible to know if the right drug was chosen. Furthermore, the reliance on laboratory testing was extremely low. Out of nearly ten thousand patients, only 221 had a sample of their blood, urine, or pus taken to identify the specific bacteria causing the infection. This means that almost all treatment decisions were made based on a doctor's best guess rather than on concrete evidence of what was inside the patient.
The types of medicines being used also raised concerns. The study showed that doctors were heavily favoring broad-spectrum antibiotics, which are powerful drugs capable of killing many different types of bacteria. These are often reserved for serious infections because their heavy use can speed up the development of resistance. In this survey, these powerful drugs, known as "Watch" antibiotics, made up more than half of all prescriptions. The most commonly used drug was ceftriaxone, followed by metronidazole. While these drugs are effective, their widespread use suggests that doctors are often reaching for the strongest tools available rather than the most targeted ones. Additionally, the vast majority of these medicines were given through a vein, even though many patients could have been treated just as well with a pill.
Despite these gaps, the researchers identified several clear signs that point the way toward better care. They found that when doctors wrote the name of the medicine in its generic form—the standard scientific name rather than a brand name—they were more likely to be following the guidelines. This suggests that sticking to the standard list of essential medicines helps doctors make better choices. Another strong indicator of good practice was the act of switching a patient from an intravenous drip to an oral pill as soon as they were well enough. Patients who received this switch were much more likely to have been treated according to the rules. The study also revealed that the level of the hospital mattered. Doctors in general hospitals followed the guidelines more often than those in regional referral hospitals or specialized institutes, suggesting that the complexity of the cases or the resources available at different levels of care influence how medicines are prescribed.
The researchers concluded that the path to better antibiotic use in Uganda lies in strengthening the systems that support doctors. This includes improving the ability of hospitals to test for bacteria so that treatments can be targeted, ensuring that every prescription has a clear reason written down, and encouraging the use of standard generic names. By focusing on these practical steps, such as reviewing prescriptions and helping doctors switch from drips to pills when appropriate, hospitals can reduce the unnecessary use of powerful antibiotics. The study does not claim to have solved the problem, but it provides a clear, data-driven map of where the current practices fall short and where targeted efforts can make the biggest difference in preserving the effectiveness of these life-saving medicines for the future.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.